Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization

Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer

(2013) Maryam Yazdanian et al.   Hepatitis Monthly

CCL19 and CCL28 Augment Mucosal and Systemic Immune Responses to HIV-1 gp140 by Mobilizing Responsive Immunocytes into Secondary Lymph Nodes and Mucosal Tissue

(2013) K. Hu et al.   JOURNAL OF IMMUNOLOGY

Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C

(2012) Ziad F Gellad et al.   ANTIVIRAL THERAPY

Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients

(2012) Rafael Esteban et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities

(2012) Farzin Roohvand et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Chemokine-based immunotherapy: delivery systems and combination therapies

(2012) Elham Mohit et al.   Immunotherapy

Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design

(2011) Farzin Roohvand et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study

(2011) Jing Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine

(2009) Christine Hartoonian et al.   CYTOKINE

Genetic co-transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus

(2008) Young Woo Han et al.   IMMUNOLOGY AND CELL BIOLOGY